Evidence map›Paper›PMID 41516388›Full record

ArticleInternational journal of molecular sciences2026

Specific Glucagon Assay System Using a Receptor-Derived Glucagon-Binding Peptide Probe.

Hajime Shigeto, Yoshio Suzuki, Shohei Yamamura

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hajime ShigetoHealth and Medical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 2217-14 Hayashi-cho, Takamatsu 761-0395, Japan.ORCID 0000-0003-0602-8736
Yoshio SuzukiHealth and Medical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Central 6, 1-1-1 Higashi, Tsukuba 305-8566, Japan.
Shohei YamamuraHealth and Medical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 2217-14 Hayashi-cho, Takamatsu 761-0395, Japan.

Funding

JSPS KAKENHI 17H07400
6 · The paper itself

Abstract

Glucagon is a peptide hormone secreted by pancreatic alpha cells which elevates blood glucose and plays a critical role in diabetes onset and homeostasis. The accurate assessment of glucagon concentration is challenging due to its structural similarity with other hormones, causing cross-reactivity in antibody-based methods. Rapid and specific glucagon detection is essential, particularly during hypoglycemia. This study aimed to develop glucagon-specific probes combining high specificity, rapid detection, and ease of operation. We designed novel peptide-based probes by screening glucagon-binding peptides from the glucagon receptor sequence using a peptide array method. This strategy, based on receptor amino acid sequences, can be applied to the identification of binding peptides for other hormones, expanding its potential utility. The screened peptides were conjugated with fluorescent dyes to create probes enabling detection within 30 min. The developed probes demonstrated superior specificity for glucagon relative to similar sequence analogs compared with conventional antibody-based methods, with detection limits in the nanomolar range. This study represents a proof-of-concept approach for rapid and highly specific glucagon detection. However, further optimization of probe sensitivity and validation under physiological conditions will be required before clinical or diagnostic application. These improvements in the probe's properties will enable the reliable blood glucagon detection and accurate diagnostic assessment of diabetes-related diseases.

Indexed as

GlucagonPeptidesReceptors, GlucagonAmino Acid SequenceBiosensing TechniquesFluorescent DyesHumansFluorescent DyesGlucagonPeptidesReceptors, Glucagonbiosensorglucagonglucagon receptor

Identifiers

PMID41516388
PMCPMC12786957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.